Axtria’s has received an honorable mention in Gartner’s Magic Quadrant for Sales Performance Management for the 3rd consecutive year. Axtria SalesIQ™ is a cloud based unified global sales planning and operations platform with embedded analytics. It enables commercial offices to create the right territories, assign the right personnel, target the right customers through the right channels and measure and reward high performance.
In addition to Axtria’s presentations and posters (mentioned in our first blog on Write the Future of Analytics with Axtria at PMSA 2019), Axtria is also leading one of the pre-conference tutorial sessions and participating in the conference panel discussion.
Axtria is delighted to announce that we will be sponsoring and participating in the Pharmaceutical Management Science Association’s (PMSA) annual conference. This will be Axtria’s ninth year attending and we are eager to explore this year’s theme: “Designing the Future of Analytics in Biopharma.”
Market dynamics are changing the medical device market in unprecedented ways. Accustomed to rapid innovation in their lives as consumers, patients are expecting data and information being generated across various personal (face-to-face interactions) and non-personal (digital interactions on the web and social channels) to be translated into delivering better healthcare outcomes and their quality of lives. The baseline of quality of delivery of healthcare throughout the ecosystem is shifting to much higher expectations, as a result. The medical devices industry faces this challenge every day.
There is an abundance of information in the healthcare world, especially with new databases emerging such as those created through patient claims, electronic health records (EHRs), social media, and new customer engagement channels. Note that electronic medical records (EMRs) generally captures a patient’s specific interactions with specific healthcare activities that result in billing. EHR data is a longitudinal aggregation of patients' EMR data over time.
We are delighted to announce that Axtria will be participating in the Pharmaceutical Management Science Association’s (PMSA) 2019 Winter Symposium in Las Vegas at The Signature at MGM Grand. This year’s theme is “Innovation in Analytics via Machine Learning & AI.”
Axtria is proud to recognize that our Principal Scientist, Dr. George A. Chressanthis, has been inducted into the Indiana University of Pennsylvania (IUP) College of Humanities and Social Sciences (CHSS) Hall of Distinction. On September 28, 2018, Dr. Chressanthis and other alumni from across the CHSS were inaugural initiates in the CHSS Hall of Distinction, an honor bestowed on less than 0.1% of CHSS graduates.
This tri-blog series delves into the need, challenges, requisites and approaches to implementing an effective global segmentation & targeting (S&T) strategy in the life sciences industry. The upside of a standardized S&T strategy has been discussed in detail in the How Harmonized Global Segmentation & Targeting Can Enhance Customer Experiencefirst blog of this series. This second blog focusses on the components of a global S&T strategy needed for its success and dives into some best practices for implementation.
We are excited to announce that Axtria will be participating in the Pharmaceutical Management Science Association’s (PMSA) second annual European Summit in Amsterdam at the iconic Hilton Amsterdam. This year’s theme is “Advanced Analytics Across the Changing EU Data Landscape.”
The tri-blog series delves into the need, challenges, and approaches to implementing an effective global segmentation & targeting strategy. The first part of the blog discusses the inherent challenges and why companies need a standardized approach and its benefits.